Archived grant โ no longer open
This grant has closed and is kept as a historical reference. Browse current grants for active opportunities.
Humanization of a Notch 3 Agonist Antibody for Pre-Clinical Development of a CADASIL Treatment
Applications closed.
Description preview
PROJECT SUMMARY
Notch 3 mutations are the cause of cerebral autosomal dominant arteriopathy with subcortical infarcts
and leukoencephalopathy (CADASIL), a small vessel disease characterized by stroke and vascular
cognitive impairment. Transgenic mouse studies from our lab and others have shown that Notch 3 sig-
naling is critical for mural cellโฆ
Full details available on the Agency plan
Unlock the complete grant description, eligibility criteria, contract value, evaluation details and apply link โ plus alerts, pipeline tracking, and CSV export.
Agency Plan
7-day free trialUnlock procurement & grants
Upgrade to access active tenders from World Bank, UNDP, ADB and more โ with email alerts and pipeline tracking.
$29.99 / month
- ๐Email alerts for new matching tenders
- ๐๏ธTrack tenders in your pipeline
- ๐ฐFilter by contract value
- ๐ฅExport results to CSV
- ๐Save searches with one click